Clinical trial

Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression

NCT05693922

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-02-09

PhaseNA

Study timeline

Study start (actual)2023-02-09Date precision: day

Registry last updated2025-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Delta-beta cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MCDEVICE

Single-session behavioral activationBEHAVIORAL

Active sham cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MCDEVICE

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

Foundation of Hope, North Carolinacollaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05693922 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.